NCT06902233招募中不适用
High-definition Transcranial Infraslow Gray Noise Stimulation for Treatment of Chronic Low Back Pain: A Double-blinded Randomised Controlled Clinical Trial.
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 164
- 试验地点
- 2
- 主要终点
- Pain intensity
研究概览
简要总结
This study looks at the non-invasive brain stimulation technique in people with chronic low back pain to see:
- How effective non-invasive brain stimulation is at improving pain intensity in people with chronic low back pain?
- How safe non-invasive brain stimulation is and what side effects there may be?
- What study participants think of the study procedures and of the non-invasive brain stimulation as a treatment technique for chronic low back pain.
Participants will be assigned to receive either active brain stimulation group or sham stimulation group randomly.
Participants will be required to attend a total of twelve treatment sessions (approximately 1-hour each, three sessions per week, for four consecutive weeks).
Assessments will be done at baseline (in the week 0), immediately post-completion of the intervention (in the week 5), and at the follow-up of one-month (in the week 8), three-months (in the week 16) and six-months (in the week 28) post-completion of intervention.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Outcomes Assessor)
盲法说明
The statistician analysing the data will also be blinded to the group allocation.
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age between 18 to 75 years on the day of screening
- •Pain in the lower back (region between 12th rib and gluteal fold) with or without accompanying leg pain that occurs for at least half the days in the last six months
- •An average pain intensity of ≥4 on the 11-point NPRS (0=No pain to 10=Pain as bad as you can imagine) in the week prior to enrolment
- •A disability score of ≥5 on Roland-Morris Disability Questionnaire (RMDQ).
排除标准
- •Known or suspected serious spinal pathology (fracture; lumbar canal stenosis, malignant, inflammatory or infective diseases of the spine; cauda equina syndrome or widespread neurological disorder)
- •Suspected or confirmed pregnancy or less than six months post-partum
- •Inflammatory disorders
- •Auto-immune conditions
- •Recent soft tissue injuries of the back in the last 3 months
- •Recent steroid injections to the back in the past 3 months
- •Recent spinal surgery in the past 12 months or scheduled/waiting for any major surgical procedures during the treatment or follow-up period or underwent rhizotomy or any neurosurgical procedures
- •History of neurological conditions, or psychiatric disorders (except depression and anxiety disorders)
- •History of cancer, or currently receiving/scheduled for receiving therapy for cancer
- •Cognitive impairments (dementia, Alzheimer's disease; indicated by a total score of 24 or below on Mini-Mental State Examination)
- •Alcohol or substance abuse
- •History of epilepsy or seizures
- •Presence of any electronic implants (e.g., pacemaker), metal implant in the body (particularly head and neck), or spinal cord stimulator.
结局指标
主要结局
Pain intensity
时间窗: The primary endpoint for efficacy assessment of HD-tIGNS will be change in the average pain intensity over the past week from baseline to one-week post completion of treatment.
Average pain intensity over the past week measured on a numeric pain rating scale (NPRS) of 0 to 10 (0=No pain to 10=Pain as bad as you can imagine) from the Brief Pain Inventory short form
次要结局
- Pain intensity(Change in the average pain intensity over the past week from baseline to one-month, three-months and six-months post completion of treatment.)
- Pain interference(Change in the pain interference from baseline to one-week, one-month, three-months and six-months post completion of treatment.)
- Pain unpleasantness(Change in the pain unpleasantness from baseline to one-week, one-month, three-months and six-months post completion of treatment.)
- Pain Bothersomeness(Change in the pain bothersomeness from baseline to one-week, one-month, three-months and six-months post completion of treatment.)
- Patient global impression of change(Recorded at one-week, one-month, three-months, and six-months post completion of treatment.)
- Movement Evoked Pain: Repeated spinal bending(Recorded at baseline, and at one-week, one-month, three-months, and six-months post completion of treatment.)
- Movement Evoked Pain: Back Performance scale(Recorded at baseline, and at one-week, one-month, three-months, and six-months post completion of treatment.)
- Mechanical temporal summation(Recorded at baseline, and at one-week, one-month, three-months, and six-months post completion of treatment.)
- Pressure Pain Threshold(Recorded at baseline, and at one-week, one-month, three-months, and six-months post completion of treatment.)
- Function(Recorded at baseline, and at one-week, one-month, three-months, and six-months post completion of treatment.)
- Health Related Quality of Life(Recorded at baseline, and at one-week, one-month, three-months, and six-months post completion of treatment.)
- Well-Being(Recorded at baseline, and at one-week, one-month, three-months, and six-months post completion of treatment.)
- Depression(Recorded at baseline, and at one-week, one-month, three-months, and six-months post completion of treatment.)
- Catastrophizing(Recorded at baseline, and at one-week, one-month, three-months, and six-months post completion of treatment.)
- Attention to pain(Recorded at baseline, and at one-week, one-month, three-months, and six-months post completion of treatment.)
- Positive and Negative Affect(Recorded at baseline, and at one-week, one-month, three-months, and six-months post completion of treatment.)
- Self-efficacy(Recorded at baseline, and at one-week, one-month, three-months, and six-months post completion of treatment.)
- Intolerance to Uncertainity scale short form(Recorded at baseline, and at one-week, one-month, three-months, and six-months post completion of treatment.)
- Tampa scale of Kinesiophobia(Recorded at baseline, and at one-week, one-month, three-months, and six-months post completion of treatment.)
- Rescue analgesics / Concomitant treatment(Recorded at baseline, and at one-week, one-month, three-months, and six-months post completion of treatment. QAQ will also be collected during intervention period, either at start of sessions (S1, S4, S7, S10) or after completion of the session (S12).)
- Electroencephalography(Recorded at baseline, and at one-week, one-month, three-months, and six-months post completion of treatment. EEG will also be collected during intervention phase either at start of the sessions (S1,S4,S7,S10) or after completion of sessions (S1 and S12).)
- Emotional Stroop Task(Recorded at baseline, and at one-week, one-month, three-months, and six-months post completion of treatment. Stroop testing will be also be done during the intervention phase either at start of sessions (S4, S7, S10) or after completion of session (S12).)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
Deep Brain Therapy With Low-intensity Ultrasound for Generalized Chronic PainChronic PainChronic Pain SyndromeWidespread Chronic PainNCT05674903University of Utah47
撤回
1 期
Noninvasive Modulation of Chronic Neuropathic PainNeuropathic PainChronic PainNCT06249724University of Utah40
终止
1 期
Ultrasonic Neuromodulation for Treatment of PTSDPTSDNCT06135064University of Utah10
尚未招募
不适用
The impact of non-invasive brain stimulation on pain in Parkinson's.Parkinson's diseaseACTRN12619000077167Professor Natalie Gasson30
已完成
4 期
Brain Imaging of Lidoderm for Chronic Back PainLow Back PainNCT01515540Northwestern University38